FDA guidance
Enhancing the Diversity of Clinical Trial Populations - Eligibility Criteria, Enrollment…
FDA guidance · Final · issued Nov 10, 2020
Key facts
| Title | Enhancing the Diversity of Clinical Trial Populations - Eligibility Criteria, Enrollment Practices, and Trial Designs |
|---|---|
| Status | Final |
| Issue date | Nov 10, 2020 |
| Topics | Design, Diversity, Ethics Committee (EC), Ethnicity, Sex, Good Clinical Practice (GCP), Human Subject Protection (HSP) |
At a glance
- 1–9 Product codes referenced
- 1–9 Recognized standards referenced
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA guidance documents
FDA guidance documents describe the agency's current thinking on regulatory topics. Drafts are issued for comment before a final version is published.
Source: U.S. Food and Drug Administration (FDA), Guidance Documents